Top Page | English | 简体中文 | 繁體中文 | 한국어 | 日本語
ACN Newswire能提供全方位的服務。對於希望向媒體、業界和金融市場披露和傳播資訊的公司和組織,我們能為您安排即時的新聞發佈。ACN Newswire的新聞稿包括英文、簡體中文、繁體中文、韓文和日文等多種語言版本。
Tuesday, 12 September 2023, 21:22 HKT/SGT
Share:

來源 Ad Scientiam
Ad Scientiam Launches International Study to Assess Disability Progression in Multiple Sclerosis With MSCopilot

PARIS, FRANCE, 2023年9月12日 - (亞太商訊)  - Ad Scientiam, a global leader in digital biomarkers, has announced a partnership with Sanofi to launch MS-DETECT, an international, multicenter, longitudinal study. MS-DETECT aims to evaluate the ability of MSCopilot(R), a medical software device, to detect early signs of disability worsening in people with multiple sclerosis (PwMS). The study will draw upon Ad Scientiam's expertise in MS and is financially supported by Sanofi.

Multiple Sclerosis (MS) is a chronic immune-mediated disease of the central nervous system that affects 2.8 million people worldwide. The disease is characterized by early inflammatory demyelination and subsequent neurodegeneration. Current clinical evaluation of PwMS relies mainly on the Expanded Disability Status Scale (EDSS), which has several limitations. To improve on these assessments, Ad Scientiam has developed MSCopilot(R), a software medical device that addresses four dimensions: ambulation/mobility, upper extremity function, cognition, and low-contrast visual acuity.

MS-DETECT's main objective is to determine MSCopilot(R)'s ability to identify subtle and early disability worsening. This will be performed by evaluating MSCopilot(R) individual and/or composite scores as compared to the Multiple Sclerosis Functional Composite (MSFC) and the EDSS.

"MS-DETECT is a pioneering large-scale longitudinal study that explores digital biomarkers for the early detection of disease progression. This study will provide important data to both clinicians and people living with MS," according to Dr. Saad Zinai, Chief Medical Officer at Ad Scientiam.

"Disability worsening in MS has been recently redefined and we now know that this progression can occur independently of relapses. With MS-DETECT, we have an opportunity to develop a digital solution to help detect and monitor the effects of smoldering disease, and evolve treatment goals for MS patients," explains Su-Peing Ng, Global Head of Medical Affairs - Specialty Care at Sanofi.

The study also aims to assess the MSCopilot(R) performance, safety, usability and satisfaction with the solution.

"Disease progression can be hard to detect in routine practice. I believe these novel digital biomarkers are key to help clinicians make appropriate treatment decisions and, ultimately, improve patients' care," said Prof. Patrick Vermersch (Lille, France), Coordinating Investigator and Chairman of the Study Steering Committee.

The MS-DETECT study will include 314 PwMS and will be conducted in the United States, Canada, Germany, Italy, Spain, Denmark and France. Several investigative sites have already been initiated in North America and Europe and first patients are expected to participate in the study during Q3 2023.
Check our LinkedIn, Facebook, Instagram pages or visit adscientiam.com

Contact Information
Saad Zinai
Chief Medical Officer
szinai@adscientiam.com
+33768008666

Matthieu Lamy
President
mlamy@adscientiam.com
+33768008666

話題 Press release summary


http://www.acnnewswire.com
From the Asia Corporate News Network

Copyright © 2025 ACN Newswire. All rights reserved. A division of Asia Corporate News Network


Latest Press Releases
Hong Kong Investor Relations Association Announces Winners of the 11th IR Awards 2025  
June 30, 2025, 23:17 HKT/SGT
Eagle Football Holdings supports Leadership Changes at Olympique Lyonnais  
June 30, 2025, 20:01 HKT/SGT
Approval in Principle (AiP) for World's First LCO2 / Methanol Carrier  
Monday, June 30, 2025 7:30:00 PM
Acropolis Rally Greece: Day 4 Sunday success and second overall for TOYOTA GAZOO Racing's Ogier  
Monday, June 30, 2025 7:15:00 PM
Mitsubishi Fuso-Hino Merger: 4 Firms Collaborate for the Future of Commercial Vehicles  
Monday, June 30, 2025 7:10:00 PM
Six Companies Establish BlueRebirth Council to Expand Use of Recycled Materials in New Vehicles  
Monday, June 30, 2025 6:25:00 PM
Honda Changes Plan to Build New Production Plant for Next-generation Fuel Cell Module in Japan  
Monday, June 30, 2025 6:20:00 PM
MHI-AC&R Receives Recommendation Award of JARAC's 42nd Excellent Energy Saving Equipment Awards  
Monday, June 30, 2025 6:00:00 PM
Ten innovative youth-led housing solutions win a total of US$40,000 in grants from Habitat for Humanity  
June 30, 2025, 12:28 HKT/SGT
The University of Osaka and Fujitsu Japan launch joint research on AI-powered education support for culturally and linguistically diverse children in Japan  
Monday, June 30, 2025 11:00:00 AM
More Press release >>
Copyright © 2025 ACN Newswire - Asia Corporate News Network
頂部 | 關於我們 | 服務 | 合作夥伴 | 聯繫 | 隱私權政策 | 使用條款 | RSS
美國: +1 214 890 4418 | 中國: +86 181 2376 3721 | 香港: +852 8192 4922 | 新加坡: +65 6549 7068 | 東京: +81 3 6859 8575